Biopharmaceuticals
HIV/AIDS
News Release - January 21, 2008
AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
Source: AIDS Healthcare Foundation
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.